J. Mark FitzGerald

8.8k citations

85 papers · 5.4k indexed · 3 hit papers · h-index 26

Physiology top 0.2%
Pulmonary and Respiratory Medicine top 0.5%
Immunology and Allergy top 0.5%
Surgery top 5%
Immunology top 5%

Co-authors: Mitchell Goldman Eugene R. Bleecker Peter Barker Viktoría Werkström Magnus Aurivillius Stephanie Sproule Geoffrey Gilmartin Louis‐Philippe Boulet
Topics: Asthma and respiratory diseases (58 papers)Respiratory and Cough-Related Research (28 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers)
Cited by: Physiology Immunology and Allergy Pulmonary and Respiratory Medicine
Journals: The LancetSHILAP Revista de lepidopterologíaPLoS ONE
Partner nations: Canada United States United Kingdom

In The Last Decade

J. Mark FitzGerald

83 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

2016 984 citations J. Mark FitzGerald, Stephanie Korn et al. profile →
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

2016 976 citations J. Mark FitzGerald et al. profile →
A summary of the new GINA strategy: a roadmap to asthma control

2015 550 citations Allan B. Becker, Louis‐Philippe Boulet et al. European Respiratory Journal profile →

Peers

Countries citing papers authored by J. Mark FitzGerald

Since Specialization

Citations

This map shows the geographic impact of J. Mark FitzGerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mark FitzGerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mark FitzGerald more than expected).

Fields of papers citing papers by J. Mark FitzGerald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mark FitzGerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mark FitzGerald. The network helps show where J. Mark FitzGerald may publish in the future.

Co-authorship network of co-authors of J. Mark FitzGerald

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mark FitzGerald. A scholar is included among the top collaborators of J. Mark FitzGerald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mark FitzGerald. J. Mark FitzGerald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Measuring skill-based health literacy in chronic airway disease patients: the development and psychometric evaluation of the Vancouver airways health literacy tool (VAHLT) 2023 ·Quality of Life Research ·(unknown),Jacek A. Kopec,Richard Sawatzky,Iraj Poureslami,J. Mark FitzGerald	1
2	Health literacy in asthma and chronic obstructive pulmonary disease (COPD) care: a narrative review and future directions 2022 ·Respiratory Research ·Iraj Poureslami,J. Mark FitzGerald,(unknown),Roger Goldstein,M. Diane Lougheed,Samir Gupta	23
3	Airway inflammation and hyperresponsiveness in subjects with respiratory symptoms and normal spirometry 2022 ·European Respiratory Journal ·Louis‐Philippe Boulet,Marie‐Ève Boulay,Andréanne Côté,J. Mark FitzGerald,Céline Bergeron,Catherine Lemière,M. Diane Lougheed,Katherine L. Vandemheen,Shawn D. Aaron	5
4	Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry 2021 ·The Journal of Allergy and Clinical Immunology In Practice ·Eve Denton,David Price,Trung N. Tran,Giorgio Walter Canonica,Andrew Menzies‐Gow,J. Mark FitzGerald,Mohsen Sadatsafavi,Luis Pérez de Llano,George Christoff,(unknown),Chin Kook Rhee,Guy Brusselle,Charlotte Suppli Ulrik,Njira Lugogo,Fiona Hore‐Lacy,Isha Chaudhry,Lakmini Bulathsinhala,Ruth Murray,Victoria Carter,Mark Hew	69
5	Efficacy and Safety of an Inhaled Anti-TSLP Antibody Fragment in Adults with Mild Atopic Asthma 2020 ·Gail M. Gauvreau,Jens M. Hohlfeld,Sarah Schmidt Grant,Meena Jain,Maciej Cabanski,Peter Pertel,LP Boulet,Donald W. Cockcroft,Beth E. Davis,J. Mark FitzGerald,Stephanie Korn,Oliver Kornmann,Richard Leigh,Irvin Mayers,(unknown),(unknown),Paul M. O’Byrne	17
6	Bridging the gap: Key informants’ perspectives on patient barriers in asthma and COPD self-management and possible solutions 2019 ·Canadian Journal of Respiratory Critical Care and Sleep Medicine ·Jessica Shum,Iraj Poureslami,(unknown),Iris van der Heide,(unknown),Laura Nimmon,(unknown),J. Mark FitzGerald	6
7	Novel Blood-based Transcriptional Biomarker Panels Predict the Late-Phase Asthmatic Response 2017 ·American Journal of Respiratory and Critical Care Medicine ·Amrit Singh,Casey P. Shannon,(unknown),Chen Xi Yang,Robert Balshaw,Gabriela V. Cohen Freue,Gail M. Gauvreau,J. Mark FitzGerald,Louis‐Philippe Boulet,Paul M. O’Byrne,Scott J. Tebbutt	16
8	Late-breaking abstract: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma 2014 ·European Respiratory Journal ·Gail M. Gauvreau,Louis‐Philippe Boulet,J. Mark FitzGerald,Donald W. Cockcroft,Beth E. Davis,Richard Leigh,Masaya Tanaka,(unknown),Makoto Tanaka,(unknown),Paul M. O’Byrne	1
9	Th17/Treg ratio derived using DNA methylation analysis is associated with the late phase asthmatic response 2014 ·Allergy Asthma and Clinical Immunology ·Amrit Singh,Masatsugu Yamamoto,Jian Ruan,(unknown),Gail M. Gauvreau,Sven Olek,(unknown),Christopher Carlsten,J. Mark FitzGerald,Louis‐Philippe Boulet,Paul M. O’Byrne,Scott J. Tebbutt	24
10	Peripheral Blood Gene Expression Changes during Allergen Inhalation Challenge in Atopic Asthmatic Individuals 2012 ·Journal of Asthma ·(unknown),Amrit Singh,Jian‐Qing He,Jian Ruan,Gail M. Gauvreau,Paul M. O’Byrne,J. Mark FitzGerald,Scott J. Tebbutt	13
11	Canadian Thoracic Society Asthma Management Continuum – 2010 Consensus Summary for Children Six Years of Age and Over, and Adults 2010 ·Canadian Respiratory Journal ·M. Diane Lougheed,Catherine Lemière,Sharon Dell,Francine M. Ducharme,J. Mark FitzGerald,Richard Leigh,Chris Licskai,Brian H. Rowe,Dennis Bowie,Allan B. Becker,Louis‐Philippe Boulet	150
12	Antibiotic Use in Children Is Associated With Increased Risk of Asthma 2009 ·PEDIATRICS ·Fawziah Marra,Carlo A. Marra,Kathryn Richardson,Larry D. Lynd,Anita L. Kozyrskyj,David M. Patrick,William Bowie,J. Mark FitzGerald	227
13	A systematic review of asthma and health literacy: a cultural-ethnic perspective in Canada. 2007 ·PubMed ·(unknown),Irving Rootman,Ellen Balka,(unknown),(unknown),J. Mark FitzGerald	39
14	Bronchial Thermoplasty for Asthma 2006 ·American Journal of Respiratory and Critical Care Medicine ·Gerard Cox,John D. Miller,Annette McWilliams,J. Mark FitzGerald,Stephen Lam	191
15	The Value of Thoracic Computed Tomography Scans in Clinical Diagnosis: A Prospective Study 2006 ·Canadian Respiratory Journal ·MARK O. TURNER,John R. Mayo,Néstor L. Müller,Michael Schulzer,J. Mark FitzGerald	8
16	Reconcilable Differences 2004 ·CHEST Journal ·Larry D. Lynd,Andrew J. Sandford,Erin Kelly,Peter D. Paré,Tony R. Bai,J. Mark FitzGerald,Aslam H. Anis	25
17	Factors Associated with Tuberculin Conversion in Canadian Microbiology and Pathology Workers 2003 ·American Journal of Respiratory and Critical Care Medicine ·Dick Menzies,Anne Fanning,(unknown),J. Mark FitzGerald	21
18	Magnesium sulfate is effective for severe acute asthma treated in the emergency department. 2000 ·Western Journal of Medicine ·J. Mark FitzGerald	11
19	Psychosocial Barriers to Asthma Education 1994 ·CHEST Journal ·J. Mark FitzGerald	22
20	Abdominal Tuberculosis: A Critical Review 1991 ·Digestive Diseases ·J. Mark FitzGerald,(unknown),R. Kevin Elwood	12

About J. Mark FitzGerald

J. Mark FitzGerald is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine, having authored 85 papers that have together received 5.4k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (58 papers), Respiratory and Cough-Related Research (28 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers). The work is most often cited by research in Physiology (4.1k citations), Immunology and Allergy (889 citations) and Pulmonary and Respiratory Medicine (3.2k citations). J. Mark FitzGerald has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Mitchell Goldman, Eugene R. Bleecker, Peter Barker, Viktoría Werkström, Magnus Aurivillius, Stephanie Sproule, Geoffrey Gilmartin, Louis‐Philippe Boulet, Alberto Papi and Pascal Chanez. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact